Core Laboratories CLB Change in Deferred Revenue
Change in Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by Core Laboratories in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.
The official record: Core Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Core Laboratories's change in deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Core Laboratories's change in deferred revenue?
- Core Laboratories (CLB) reported change in deferred revenue of -$844K in Q1 2026.
- How has Core Laboratories's change in deferred revenue changed year-over-year?
- Core Laboratories's change in deferred revenue decreased by 291.8% year-over-year, from $440K to -$844K.
- What is the long-term trend for Core Laboratories's change in deferred revenue?
- Over 2 years (2021 to 2025), Core Laboratories's change in deferred revenue has grown at a 28.0% compound annual growth rate (CAGR), from $2.31M to -$3.78M.
- What does change in deferred revenue mean?
- Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.